Join Now

PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device

Funding supports key milestones as the Pivotal, Phase 3 trial surpasses 200 enrolled participants.

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device

PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board

PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

Groundbreaking at-home pivotal trial of a much-anticipated therapeutic device is underway.

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Enrolls First 25 Patients in Pivotal Parkinson’s Disease Study to Improve Symptoms Beyond the Current Standard of Care

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of Life

Posted in BioUtah News | Tagged | Comments Off on PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease

PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization

Posted in BioUtah News | Tagged | Comments Off on Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease